Genmab A/S (CPH:GMAB)
Denmark · Delayed Price · Currency is DKK 1,992.00
-7.00 (-0.35%)
Aug 10, 2026, 4:59 PM CET
Genmab Stock Forecast
Stock Price Forecast
According to 18 analysts polled by S&P Global, Genmab stock has a consensus rating of "Buy" and an average price target of kr 2,404. The average 1-year stock price forecast is 20.68% higher than the current stock price, while the lowest is kr 1,400 (-29.72%) and the highest is kr 2,932 (+47.19%).
Price Target: kr 2,404 (+20.68%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Genmab stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 8 | 9 | 10 | 11 | 11 | 13 |
| Buy | 2 | 1 | 2 | 2 | 2 | 2 |
| Hold | 5 | 5 | 3 | 3 | 3 | 2 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 16 | 16 | 16 | 17 | 17 | 18 |
Financial Forecast
Revenue This Year
4.58B
from 3.72B
Increased by 23.20%
Revenue Next Year
5.32B
from 4.58B
Increased by 16.18%
EPS This Year
12.18
from 17.72
Decreased by -31.28%
EPS Next Year
17.13
from 12.18
Increased by 40.71%
EPS and Forward PE are based on non-GAAP adjusted numbers.